journal article·2025-06-12

Copper Sulfide-Decorated Gd2O3 Nanorods: A Promising Probe for Magnetic Resonance Imaging and Photothermal Therapy

Dan Wang, Yunhong Xie, Lingfan Xu, Yixuan Zhou, Kai Li, Zhongfeng Li

The Journal of Physical Chemistry C· Volume 129· Issue 23
Publisher page

Abstract

The development of bifunctional nanoplatform-based theranostics has garnered considerable attention in cancer therapy research. In this study, we engineer Gd 2 O 3 @SiO 2 -CuS nanorods as an integrated diagnostic-therapeutic system, simultaneously harnessing photothermal conversion and paramagnetic properties for MRI-assisted photothermal intervention. Hydrothermally synthesized Gd 2 O 3 nanorods demonstrate superior T 1 -weighted contrast performance, achieving a longitudinal relaxivity ( r 1 ) of 4.2 mM –1 ·s –1, which compares favorably with that of commercial contrast agents. Furthermore, the strategically integrated CuS component exhibits remarkable photothermal conversion efficiency (19.6%) and sustained therapeutic stability. These attributes pave the way for achieving the application objective of magnetic resonance imaging-assisted photothermal therapy. Critically, comprehensive biosafety evaluations, including hemocompatibility assays and cytotoxicity profiling, confirm the nanocomposite’s favorable biocompatibility. The findings underscore the substantial potential of Gd 2 O 3 @SiO 2 -CuS nanorods for image-guided photothermal therapy applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry

Capital Normal University

Funding

National Natural Science Foundation of China

References (38)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1002/cncr.3534710.1002/cncr.35347 ↗
3. 10.1038/s41568-024-00690-x10.1038/s41568-024-00690-x ↗
4. 10.1016/j.biopha.2023.11507010.1016/j.biopha.2023.115070 ↗
5. 10.1016/j.cej.2022.13714710.1016/j.cej.2022.137147 ↗
6. 10.3390/molecules2801027710.3390/molecules28010277 ↗
7. 10.1039/D1NR05449J10.1039/D1NR05449J ↗
8. 10.1016/j.dyepig.2023.11181210.1016/j.dyepig.2023.111812 ↗
9. 10.1039/D4TC01535E10.1039/D4TC01535E ↗
10. 10.1002/adhm.20230111610.1002/adhm.202301116 ↗
11. 10.1186/s12951-023-02072-110.1186/s12951-023-02072-1 ↗
12. 10.1016/j.canlet.2016.12.02610.1016/j.canlet.2016.12.026 ↗
13. 10.1186/s12951-023-02280-910.1186/s12951-023-02280-9 ↗
14. 10.2147/IJN.S28741510.2147/IJN.S287415 ↗
15. 10.1039/D1NH00291K10.1039/D1NH00291K ↗
16. 10.1016/j.actbio.2018.03.03510.1016/j.actbio.2018.03.035 ↗
17. 10.1016/j.cej.2022.13886410.1016/j.cej.2022.138864 ↗
18. 10.1021/acsami.8b0933010.1021/acsami.8b09330 ↗
19. 10.1021/acs.accounts.7b0029410.1021/acs.accounts.7b00294 ↗
20. 10.1002/smll.20170243110.1002/smll.201702431 ↗
21. 10.1016/j.dyepig.2022.11017410.1016/j.dyepig.2022.110174 ↗
22. 10.1016/j.dyepig.2022.11008010.1016/j.dyepig.2022.110080 ↗
23. 10.3390/nano1313200310.3390/nano13132003 ↗
24. 10.1007/s12274-023-6214-910.1007/s12274-023-6214-9 ↗
25. 10.1016/j.dyepig.2019.03.04810.1016/j.dyepig.2019.03.048 ↗
26. 10.1007/BF0318431610.1007/BF03184316 ↗
27. 10.1007/s00259-022-05830-910.1007/s00259-022-05830-9 ↗
28. 10.1021/acsanm.3c0427210.1021/acsanm.3c04272 ↗
29. 10.1007/s11426-023-1898-410.1007/s11426-023-1898-4 ↗
30. 10.1002/adhm.20200178010.1002/adhm.202001780 ↗
31. 10.1039/C5NR08402D10.1039/C5NR08402D ↗
32. 10.1039/C5TB02619A10.1039/C5TB02619A ↗
33. 10.1039/b925097b10.1039/b925097b ↗
34. 10.1039/D0NR90135K10.1039/D0NR90135K ↗
35. 10.1039/C4TB00919C10.1039/C4TB00919C ↗
36. 10.1016/j.mattod.2015.11.00610.1016/j.mattod.2015.11.006 ↗
37. 10.1039/C2TB00243D10.1039/C2TB00243D ↗
38. 10.1021/acsami.2c0650310.1021/acsami.2c06503 ↗